Novacyt S.A. Stock
Your prediction
Novacyt S.A. Stock
A loss of -1.770% shows a downward development for Novacyt S.A..
Our community identified positive and negative aspects for Novacyt S.A. stock for the coming years. 1 users see the criterium "Valuation (undervalued/overvalued)" as a plus for the Novacyt S.A. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Novacyt S.A. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novacyt S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novacyt S.A. | -1.770% | - | - | - | - | - | - |
| Sensorion SA | -3.090% | -6.250% | -6.716% | - | - | - | - |
| Cerenis Therapeutics Holding S.A. | 0.740% | -3.191% | -18.871% | 119.807% | -20.408% | 113.615% | 122.313% |
| Genoway S.A. Inh. | 5.430% | 4.018% | 2.193% | -25.321% | -6.048% | -37.867% | -40.333% |
